111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
13.90%
Revenue growth at 50-75% of VMC's 27.37%. Martin Whitman would worry about competitiveness or product relevance.
-67.09%
Negative gross profit growth while VMC is at 79.10%. Joel Greenblatt would examine cost competitiveness or demand decline.
-93.13%
Negative EBIT growth while VMC is at 239.08%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-93.13%
Negative operating income growth while VMC is at 239.08%. Joel Greenblatt would press for urgent turnaround measures.
13.90%
Net income growth under 50% of VMC's 462.36%. Michael Burry would suspect the firm is falling well behind a key competitor.
8.33%
EPS growth under 50% of VMC's 481.82%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
8.33%
Diluted EPS growth under 50% of VMC's 481.82%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.01%
Share reduction while VMC is at 0.09%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.05%
Reduced diluted shares while VMC is at 0.11%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
187.25%
Similar 10Y revenue/share CAGR to VMC's 189.35%. Walter Schloss might see both firms benefiting from the same long-term demand.
60.19%
5Y revenue/share CAGR at 75-90% of VMC's 67.31%. Bill Ackman would encourage strategies to match competitor’s pace.
16.73%
3Y revenue/share CAGR at 75-90% of VMC's 21.59%. Bill Ackman would expect new product strategies to close the gap.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
165.62%
Net income/share CAGR 1.25-1.5x VMC's 138.05%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
32.81%
5Y net income/share CAGR above 1.5x VMC's 3.67%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-36.76%
Negative 3Y CAGR while VMC is 3.67%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
63.54%
3Y equity/share CAGR above 1.5x VMC's 32.16%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
